Sales of Atopic Dermatitis to Grow Ten-Fold as Key Companies Line up for Fast-Track Approval & Product Development In its latest report, Fact.MR presents an elaborate analysis of various factors influencing the global atopic dermatitis market, including drivers, opportunities, restraints, and trends. It further delves deeper into major observations concerning prominent expansion parameters prevailing across key segments, including drug class, distribution channel, and regions. NEW YORK, Nov. 28, 2022 /PRNewswire/ -- The global atopic dermatitis market is poised to expand at 24% CAGR between 2022 and 2032, surpassing a valuation of US$ 7.3 Billion by the end of 2022. Growth in the market is primarily attributed to the rising prevalence of eczema and other skin disorders across the globe. In 2020, as per the Acta Derm Venereologica Journal, prevalence of doctor diagnosed atopic dermatitis in Europe was 17.1% and 22.6% of children in Asia. This is encouraging the government bodies and health professionals to develop a cure and treatment rapidly. Consequently, leading companies are extensively investing in research to develop proper drug and biologics to reduce the global burden. Download A Free Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=4603
Further, with rising awareness regarding the skin disease along with improved healthcare infrastructure in developed economies such as U.S., Japan, U.K., and Germany, the demand in the market is predicted to rise. As per Fact.MR, the leading companies are introducing innovative procedure and formulations to gain competitive edge. Based on drug class, the biologics drugs segment is poised to expand at a whopping 32.4% CAGR during the forecast period.
In terms of distribution channel, the retail pharmacies segment is slated to grow at a CAGR of 27.4% over the upcoming decade.
Europe is expected to dominate the global atopic dermatitis market, registering growth at 25.5% CAGR for the forecast period. Increasing prevalence of atopic dermatitis coupled with rising approval of drugs & treatments in the U.S. will push the growth in North America. China is expected to witness impressive growth in the East Asia atopic dermatitis market on the back of rising number of CROs and other research organizations. Increased spending on healthcare and favorable policies in India will push the demand for atopic dermatitis in South Asia market. Fast track drug approvals and extensive research & development for the product development is expected to drive the demand in the market. Availability of treatment and drugs across online pharmacies will spur the demand in the market.
Growing awareness regarding the disease coupled with favorable policies and initiatives by non-profit organizations is anticipated to boost the market.
Side effects of the biologics and the treatment for atopic dermatitis might hamper the growth in the market. High treatment cost in developing countries coupled with lack of reimbursement policies is likely to limit the sales.
Don't Need a Global Report? Save 40% on Country & Region Specific Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4603
They are also focusing on product development and fast drug approvals from regulatory authorities such as the U.S. Food and Drug Administration (FDA) to gain competitive edge. Meanwhile, other players are forming alliances with leading companies to expand their product portfolio and capitalize on the established brand of the leading company. Almirall, S.A., a global biopharmaceutical company, focused on skin health, in Key Companies Profiled by Fact.MR
In the latest study, Fact.MR reveals key factors expected to boost the growth in global atopic dermatitis market during the forecast period (2022-2032). The survey also provides an in-depth analysis of opportunities and drivers projected to propel sales of atopic dermatitis through detailed segmentation as follows: Get Full Access of this Report through our Secure Payment Gateway
https://www.factmr.com/checkout/4603
What will be the demand outlook for the atopic dermatitis market during the forecast period? Which region will lead the growth in the global atopic dermatitis market during 2022-2032? Which drug class will generate maximum revenue in the global atopic dermatitis market? Explore Fact.MR's Coverage on the Healthcare Domain
Skin Antiseptic Market: With increasing prevalence of chronic skin disorders, the demand for skin antiseptic is expected to surge at a rapid pace. Due to the rising number of infection and contamination with pathogenic organisms, the need for proper treatment has increased the demand for skin antiseptics over the upcoming decade. As per the study, Europe is expected to dominate the market, with the U.K. leading the growth. Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership. Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Follow Us: LinkedIn | Twitter | YouTube
Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg